Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EUCR NASDAQ:HCVI NASDAQ:MCAA NASDAQ:RFAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsHCVIHennessy Capital Investment Corp. VI$11.40+14.2%$10.77$5.78▼$14.00$166.91M0.0635,815 shs21,297 shsMCAAMountain & Co. I Acquisition Corp.$11.39$11.39$11.18▼$12.34$160.94M0.0166,611 shsN/ARFAIRF Acquisition Corp II$10.53-0.1%$10.52$10.04▼$10.56$158.08MN/A43,652 shs6,759 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%HCVIHennessy Capital Investment Corp. VI0.00%0.00%0.00%+5.56%+7.75%MCAAMountain & Co. I Acquisition Corp.0.00%0.00%0.00%0.00%-2.23%RFAIRF Acquisition Corp II0.00%-0.28%+0.19%+1.25%+1,052,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AHCVIHennessy Capital Investment Corp. VIN/AN/AN/AN/AN/AN/AN/AN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCREucrates Biomedical Acquisition 0.00N/AN/AN/AHCVIHennessy Capital Investment Corp. VI 0.00N/AN/AN/AMCAAMountain & Co. I Acquisition Corp. 0.00N/AN/AN/ARFAIRF Acquisition Corp II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCREucrates Biomedical AcquisitionN/AN/A$0.81 per share12.36($1.25) per shareN/AHCVIHennessy Capital Investment Corp. VIN/AN/A$0.60 per share19.09($0.53) per shareN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCREucrates Biomedical Acquisition$2.42MN/A0.00∞N/AN/A-62.82%2.95%N/AHCVIHennessy Capital Investment Corp. VI$6.40M-$1.27N/A∞N/AN/AN/A-14.82%N/AMCAAMountain & Co. I Acquisition Corp.N/AN/A0.00∞N/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AHCVIHennessy Capital Investment Corp. VIN/AN/AN/AN/AN/AMCAAMountain & Co. I Acquisition Corp.N/AN/AN/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEUCREucrates Biomedical AcquisitionN/A2.032.03HCVIHennessy Capital Investment Corp. VIN/A0.560.56MCAAMountain & Co. I Acquisition Corp.N/AN/AN/ARFAIRF Acquisition Corp IIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCREucrates Biomedical Acquisition56.02%HCVIHennessy Capital Investment Corp. VI59.54%MCAAMountain & Co. I Acquisition Corp.64.23%RFAIRF Acquisition Corp IIN/AInsider OwnershipCompanyInsider OwnershipEUCREucrates Biomedical Acquisition19.50%HCVIHennessy Capital Investment Corp. VI30.51%MCAAMountain & Co. I Acquisition Corp.4.18%RFAIRF Acquisition Corp IIN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEUCREucrates Biomedical Acquisition44.21 million3.39 millionNot OptionableHCVIHennessy Capital Investment Corp. VI314.64 million10.17 millionNot OptionableMCAAMountain & Co. I Acquisition Corp.2,02114.13 million13.54 millionNot OptionableRFAIRF Acquisition Corp IIN/A15.01 millionN/AN/AEUCR, HCVI, MCAA, and RFAI HeadlinesRecent News About These CompaniesRF Acquisition Corp II (NASDAQ:RFAI) Trading Up 0.3% - Still a Buy?July 2, 2025 | americanbankingnews.comRF Acquisition Corp II (NASDAQ:RFAI) Trading Up 0.3% - Time to Buy?July 2, 2025 | marketbeat.comRF Acquisition Corp II Audit Committee ResignationMay 21, 2025 | tipranks.comMedia Sentiment Over TimeEUCR, HCVI, MCAA, and RFAI Company DescriptionsEucrates Biomedical Acquisition NASDAQ:EUCREucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Hennessy Capital Investment Corp. VI NASDAQ:HCVI$11.40 +1.42 (+14.23%) As of 06/5/2025Hennessy Capital Investment Corp. VI does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the industrial technology sectors in the United States. The company was incorporated in 2021 and is based in Zephyr Cove, Nevada.Mountain & Co. I Acquisition Corp. NASDAQ:MCAA$11.39 0.00 (0.00%) As of 05/27/2025Mountain & Co. I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in consumer Internet and B2B digital infrastructure sectors. The company was incorporated in 2021 and is based in Wilmington, Delaware.RF Acquisition Corp II NASDAQ:RFAI$10.53 -0.01 (-0.09%) As of 12:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.RF Acquisition Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 5, 2024, and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Robinhood Stock Gets 5 Price Target Upgrades, Signaling Upside AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
